Novo Integrated Sciences ...

OTC: NVOS · Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 03, 2025, 10:15 AM

Novo Integrated Sciences Income Statement

Financials in USD. Fiscal year is September - August.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Aug 31, 2024 Aug 31, 2023 Aug 31, 2022 Aug 31, 2021
Revenue
13.29M 12.57M 11.74M 9.31M
Cost of Revenue
7.55M 7.62M 6.94M 5.48M
Gross Profit
5.74M 4.95M 4.8M 3.82M
Operating Income
-10.08M -8.55M -25.03M -4.37M
Interest Income
202.53K 9.03K 169.09K 45.69K
Pretax Income
-16.13M -13.27M -33.07M -4.47M
Net Income
-16.13M -13.21M -32.85M -4.46M
Selling & General & Admin
14.06M 13.51M 14.39M 8.1M
Research & Development
n/a n/a n/a n/a
Other Expenses
n/a n/a n/a 21.9K
Operating Expenses
14.06M 13.51M 14.39M 8.1M
Interest Expense
-652.4K 5.12M 7.57M 165K
Selling & Marketing Expenses
17.14K 15.15K 20.7K 7.53K
Cost & Expenses
21.61M 21.13M 21.32M 13.58M
Income Tax Expense
n/a n/a -22.3K 178.12K
Shares Outstanding (Basic)
18.03M 10.17M 2.91M 2.48M
Shares Outstanding (Diluted)
18.03M 10.17M 2.91M 2.48M
EPS (Basic)
-0.89 -1.3 -11.28 -1.8
EPS (Diluted)
-0.89 -1.3 -11.28 -1.8
EBITDA
-10.08M -5.85M -22.48M -2.58M
EBIT
-16.78M -8.15M -25.5M -4.31M
Depreciation & Amortization
n/a 2.3M 3.02M 2.37M